Spinning a solution in healthcare from a basic technology requires phased research from basic to translational, pre-clinical and clinical studies, for which Japan has a wholesome ecosystem; GN Corp track record, interviewed for a feature story, sponsored by Government of Japan, published in Bloomberg.
Neu REFIX beta glucans improving Multiple Sclerosis patients’ gut microbiome awarded as the best poster in 6th Microbiome Asia Conference in Tokyo 26~27 April 2023
1/5/2023
Neu REFIX beta glucans improving Multiple Sclerosis patients’ gut microbiome awarded as the best poster
